Skip to content
value.today

Surmodics, Inc.

SRDXUnlisted company
$487 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$105 M
Sep-2021 ending year
value.today research
Net income
$4 M
3.8% margin
value.today research
Employees
—

Surmodics, Inc. in brief

Surmodics, Inc. is an unlisted company in the Medical Devices industry, based in Minnesota, USA. It was founded in 1979. In the year to Sep 2021 it had sales of $105 M and a net profit of $4 M, about 4 cents of profit for every dollar of sales.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Surmodics, Inc.

SurModics is the leader in surface modification technologies for intravascular medical devices and a provider of chemical components for in vitro diagnostic (IVD) tests and microarrays. The headquarters is in USA.

Surmodics company annual revenue was 99 million USD and annual net loss was -27 as on Sep-2022.

Surmodics, Inc. timeline

2 events, 1979–1998
  1. 1979
  2. 🏁
    · approximate
    Founded
  3. 1998
  4. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Surmodics, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Surmodics, Inc.

Acquisitions and changes
No longer listed: ticker SRDX is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$177 M$353 M$530 M$706 M20202021202220232024

World rank over time

▼ down 2,291 places since 2020
2020-01-01: #10500#10,50020202021-01-01: #10336#10,33620212022-01-07: #11823#11,82320222022-12-25: #12916#12,91620222023-07-30: #13352#13,35220232024-01-05: #12791#12,7912024

Rank in USA: #2,400 (Jan 2020) · #2,614 (Jan 2021) · #2,973 (Jan 2022) · #2,682 (Dec 2022) · #2,780 (Jul 2023) · #2,566 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
3.8%
Operating margin
—
Return on equity
2.9%
Liabilities / assets
27.8%

Annual results

Revenue
$105 M
Operating income
—
Net income
$4 M

Sep-2021 ending year

Balance sheet

Total assets
$194 M
Total liabilities
$54 M
Total equity
$140 M

Sep-2021 ending year

Markets and events: Surmodics, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2025-11-14
474,950
1 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2025-11-19 00:50 UTC, code D, resumed 05:00 UTC
  • 2025-11-10 19:45 UTC, code T3, resumed 12:00 UTC

Fails to deliver

  • : 104,277 shares at $42.98
  • : 8,640 shares at $42.83
  • : 6,523 shares at $41.41
  • : 699 shares at $40.94
  • : 46 shares at $28.32

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

H-1B hiring at Surmodics, Inc.#

1 labor condition applications certified in fiscal 2023 for 1 positions, at a median wage of $78 K a year.

Certified, FY2023
1
#1,907 among companies on value.today
Worker positions
1
Median wage offered
$78 K
a year, full-time
Applications filed
1
Surmodics, Inc.: most frequent H-1B job titles in fiscal 2023
Job titlePositionsMedian wage offered
Regulatory Affairs AssociateRegulatory Affairs Specialists1$78 K

Where: Eden Prairie, MN 1

Surmodics, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202311$78 K1
FY202011$78 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Surmodics, Inc.

How Surmodics, Inc. compares in Medical Devices

  • Revenue$105 M · higher than 42% of 155
  • Net margin3.8% · higher than 61% of 144

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Surmodics, Inc.🇺🇸$487 M—3.8%—
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
Sep-2021 ending year
Balance sheet:
Sep-2021 ending year
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Surmodics, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Surmodics, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Surmodics, Inc.? Suggest a correction